According to the Zhitong Finance App, Fengyuan Pharmaceutical (000153.SZ) issued an announcement. Recently, the company received the “Drug Registration Certificate” for paramivir injections approved and issued by the State Drug Administration. This medicine is used to treat influenza A or B Obtaining a registration certificate this time will enrich the company's product line, optimize the company's product structure, and help enhance the company's market competitiveness.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.